← Full nasal congestion algorithm
Reasoning GP · Algorithm · 1-page summary

Nasal congestion and rhinorrhoea

For: adults and children with a blocked or runny nose in primary care. Not for: starting immunotherapy or biologics (specialist-led), or managing orbital, intracranial or CSF-leak complications (hospital).
Reviewed October 2026 · next review April 2027
NICE NG79BSACI rhinitis 2017EPOS 2020MHRA decongestants 2026NICE NG12
Core rule: bilateral congestion is usually rhinitis or sinusitis; persistent one-sided blockage, blood-stained discharge or clear watery discharge is not. Never keep treating one-sided symptoms as rhinitis.

0Stop — emergency now — before any treatment

  • Suspected button battery in the nose → 999; do not attempt removal. Foreign body with respiratory distress or aspiration risk, significant facial swelling or airway compromise → Emergency
  • Sinusitis with periorbital swelling, proptosis, painful or restricted eye movements, diplopia or reduced vision; severe headache, meningism, neurological signs or sepsis → Immediate hospital
  • One-sided clear watery discharge (possible CSF leak) with fever, severe headache, meningism, confusion or reduced consciousness → Emergency (possible meningitis)
  • While waiting: do not delay transfer for imaging, beta-2 transferrin or a set antibiotic; no nasal instrumentation. Antibiotic choice per hospital protocol.

1Triage — one side or both, and how long

PatternThink → action
One side, persistentStructural disease incl. malignancy → Urgent ENT (block 2)
One side, clear, wateryCSF leak → Same-day (block 2)
Child, one side, smellyForeign body; not visible or not removable → Same-day
Both sides, <4 weeksViral URTI, acute sinusitis or allergic → NG79 10-day rule
Both sides, >12 weeksRhinitis, suspected CRS ± polyps

2Screen — one row is enough

  • Persistent one-sided obstruction, blood-stained or offensive discharge, recurrent one-sided epistaxis, facial pain or swelling, anosmia, mass or neck nodes → Urgent ENT (local pathway; not an NG12 criterion).
  • Suspected CSF leak (after head injury or surgery; salty taste) → Same-day ENT / neurosurgery / ED; testing via hospital.
  • Young male: obstruction + epistaxis + headache, cranial-nerve palsies (angiofibroma) → Urgent ENT; never biopsy or manipulate.
  • Saddle nose, septal perforation, crusting, auricular chondritis, eye inflammation, lung or kidney signs (GPA, polychondritis, cocaine) → Urgent ENT / rheumatology; consider FBC, U&E, CRP/ESR, urinalysis, ANCA.

3Assess — once blocks 0–2 are answered

☐ Anterior rhinoscopy: side, polyps, crusting, perforation  ☐ Visual acuity and eye movements if facial or periorbital symptoms  ☐ BP and pulse before a sympathomimetic decongestant

Ask: decongestant sprays, NSAID reactions, cocaine, occupation, pregnancy, asthma. Usually no tests. No routine CT in primary care.

4Classify — only if the screen is negative

  • Allergic rhinitis — sneezing, itch, watery discharge, triggers, ± asthma → block 5.
  • Acute sinusitis — bacterial more likely if >10 days, one-sided facial pain, fever, double-sickening.
  • Suspected CRS ± polyps — >12 weeks, ≥2 of blockage, discharge, facial pain, reduced smell.
  • Non-allergic — vasomotor, pregnancy, occupational; rhinitis medicamentosa (spray >5 days → stop, INCS + saline).
  • Uncertain or one-sided — not rhinitis; follow block 2.

5Treat today — doses: NICE/SPC, BNF, local formulary

  • Allergic: mild intermittent → non-sedating oral or nasal antihistamine. Moderate–severe or persistent → regular intranasal steroid (INCS); teach technique. Not controlled → check adherence, technique; consider INCS + intranasal antihistamine. Ipratropium if watery.
  • Acute sinusitis: ≤ about 10 days → no antibiotic, self-care. ≥ about 10 days, not improving → consider 14-day high-dose nasal steroid (≥12 y) and no or back-up antibiotic. Immediate only if systemically very unwell, serious illness or high risk. Phenoxymethylpenicillin; allergy → doxycycline (not pregnancy), clarithromycin or (pregnancy) erythromycin; very unwell or worse on first choice → co-amoxiclav.
  • CRS/polyps: mometasone + saline; no routine oral steroid. Decongestant sprays ≤5 consecutive days (MHRA). Pregnancy: saline, INCS; no routine oral decongestant.

6Refer routinely — urgent routes are in blocks 0–2

  • Suspected CRS despite INCS + saline, polyps, significant septal deviation → ENT.
  • Polyps + asthma + NSAID reactions (AERD) → respiratory/ENT; no aspirin challenge.
  • Troublesome allergy despite treatment + confirmed sensitisation → allergy (immunotherapy). Occupational → occupational health or allergy; check for asthma.

7Never reassure by

  • Calling persistent one-sided blockage or bloody discharge "rhinitis" or "a polyp".
  • Labelling a clear watery drip after head injury or surgery "a cold".
  • Discoloured discharge as a reason for antibiotics.
  • A "failed" nasal steroid before checking technique, adherence and duration.
  • Normal bloods or ANCA as excluding GPA.
  • Pregnancy rhinitis when there are red flags or one-sided symptoms.

8Safety-net — say it, then document it

999 “Call 999 for a possible button battery in the nose, confusion or drowsiness, a fit, or rapidly worsening vision.” A&E “Go to A&E now for eye swelling, double or reduced vision, painful eye movements, severe headache, stiff neck, feeling very unwell, or a one-sided clear drip with fever or headache.” Same day: “Contact us today if symptoms worsen quickly, even on antibiotics.” Book a review: “if sinusitis is not better after 3 weeks, a new spray is not working at 4–6 weeks, or one side stays blocked or bleeds.”

✓Safe to leave primary care only if — all five, documented

No block 0–2 feature; symptoms bilateral, or one-sided route arranged Nose examined; eyes checked if facial symptoms Decongestant use, drugs, pregnancy and asthma asked Plan fits the pattern; spray technique taught; NG79 10-day rule applied Safety-net given; review at 4–6 weeks if new treatment
Summary of the full Reasoning GP nasal congestion algorithm, which holds the history, examination, CRS criteria, immunotherapy, biologics and lifestyle detail. Sources: NICE NG79; NICE CKS allergic rhinitis; BSACI rhinitis guideline (2017); EPOS 2020; MHRA Drug Safety Update (April 2026, nasal decongestants); NICE NG12 (updated April 2026); NICE TA1045, TA1087, TA1134; local formulary. Clinical reference — follow local ENT pathways and check doses: NICE/SPC, BNF.